Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ionizing radiation and chronic lymphocytic leukemia.

David B Richardson1, Steve Wing, Jane Schroeder

  • 1Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-8050, USA. david_richardson@unc.edu

Environmental Health Perspectives
|January 1, 2005
PubMed
Summary

Chronic lymphocytic leukemia (CLL) is wrongly classified as nonradiogenic by U.S. compensation rules. This review presents evidence that ionizing radiation exposure may increase CLL risk, challenging current policy for nuclear weapons workers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combining Observational Studies to Reduce Multiple Biases.

Epidemiology (Cambridge, Mass.)·2026
Same author

Ionising radiation and cancer: a UN review of the recent epidemiological evidence.

The Lancet. Oncology·2026
Same author

Spatial analysis of residential location at birth, PFAS in public water, and childhood cancers in Southern California (2000-2019).

Journal of exposure science & environmental epidemiology·2026
Same author

Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Uranium mining and lung cancer: a legacy of the nuclear age.

Carcinogenesis·2025

Area of Science:

  • Radiation oncology
  • Epidemiology
  • Molecular biology
  • Cancer research

Background:

  • U.S. government compensation rules exclude chronic lymphocytic leukemia (CLL) from radiation-related cancer claims.
  • These rules operate under the assumption that radiation exposure does not cause CLL, leading to automatic claim rejections.
  • This policy impacts individuals with cancer exposed to ionizing radiation in the nuclear weapons complex.

Purpose of the Study:

  • To review and synthesize molecular, clinical, and epidemiologic evidence on the radiogenicity of chronic lymphocytic leukemia (CLL).
  • To evaluate the scientific basis for classifying CLL as a nonradiogenic cancer.
  • To inform U.S. government compensation policies regarding radiation exposure and CLL.

Main Methods:

Related Experiment Videos

  • Comprehensive literature review of molecular, clinical, and epidemiologic studies.
  • Analysis of current understanding of radiation-induced tumorigenesis and lymphatic neoplasia etiology.
  • Evaluation of challenges in epidemiologic assessment of CLL risk due to its clinical characteristics.

Main Results:

  • Mechanistic understanding of radiation carcinogenesis and lymphatic cancers supports a potential link with ionizing radiation.
  • Clinical features of CLL, including long latency and low fatality, complicate epidemiologic risk assessment.
  • Existing epidemiologic evidence for external radiation exposure and CLL is weak but consistent with elevated risk after decades.

Conclusions:

  • The current classification of CLL as nonradiogenic lacks a persuasive scientific basis.
  • Ionizing radiation exposure may increase the risk of developing chronic lymphocytic leukemia.
  • Re-evaluation of compensation rules for nuclear workers with CLL is warranted based on scientific evidence.